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Cardiovascular disease (CVD) and its predisposing risk factors are major lifestyle and behavioral determinants of longevity. Dietary
lifestyle choices such as a heart healthy diet, regular exercise, a lean weight, moderate alcohol consumption, and smoking cessation
have been shown to substantially reduce CVD and increase longevity. Recent research has shown that men and women who adhere
to this lifestyle can substantially reduce their risk of coronary heart disease (CHD). The preventive benefits of maintaining a
healthy lifestyle exceed those reported for using medication and procedures. Among the modifiable preventive measures, diet is
of paramount importance, and recent data suggest some misconceptions and uncertainties that require reconsideration. These
include commonly accepted recommendations about polyunsaturated fat intake, processed meat consumption, fish choices and
preparation, transfatty acids, low carbohydrate diets, egg consumption, coffee, added sugar, soft drink beverages, glycemic load,
chocolate, orange juice, nut consumption, vitamin D supplements, food portion size, and alcohol.
1. Introduction
Healthy choices and behaviors influence CVD incidence and
mortality. However, changing our dietary lifestyle in order
to avoid cardiovascular disease is not easy. To succeed in
reducing CVD, dietary alterations have to bemaintained long
term, which is a much more difficult task than taking pills.
As a result, both patients and physicians gravitate toward
medication for lowering CVD risk and prolonging life with
only cursory attempts at changing lifestyle behaviors such as
eating habits. There is the unfortunate perception that even
with intensive counseling, risk factor modification by dietary
means is trivial. Recent research indicates that this is not the
case and that the necessary behavior modification regarding
the diet can be achieved and confers a substantial benefit
when implemented in conjunction with other behavior
modification [1].
2. Methods
We performed a systematic review focused mainly on large
trials with about 1900 subjects andmeta-analyses of evidence
for relationships of dietary factors with incident CHD, CVD,
stroke, and diabetes mellitus. We searched for any cohort
study, case-control study, or randomized trial that assessed
these exposures and outcomes in generally healthy adults
or subjects with overt CVD. We completed a Google search
using keywords such as healthy lifestyle, healthy behaviors,
CVD, CHD, stroke, and diabetes. Thus, this paper is based
mainly on a 2000–2010 Internet search for well-designed
relevant trials and data that confirm and quantify established
dietary recommendations and novel nutritional data, shown
or alleged to be alterable by changes in behavior and to be
beneficial for CVD risk factor control.
3. Results
Despite decades of efforts to control them, half of USA adults
still have unacceptable CVD risk factors. The latest NHANES
survey (1999–2006) shows that 45% had one of the three
major risk factors: 30.5% had hypertension, 26% high blood
cholesterol, and 9.9% diabetes. About 13% had two of the
conditions and 3% had all three. The risk factor rates were
higher in blacks and 15% were unaware of having these
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conditions. The fraction of persons with one ormore of these
conditions and unaware of it was consistent across all ethnic
groups. With 60% of adults and 30% of younger Americans
obese, the CVD risk burden threatens to worsen. We appear
to be headed for a generation with poorer health than the
preceding one, which is unique [2].
Lifestyle, in general, and the diet we choose to eat, in
particular, affects each of the major risk factors. A number of
nutritional behaviors are recommended for avoiding cardio-
vascular risk factors and thereby prolonging our lifespan. In
addition to recommendations for medicating hypertension,
HDL-C, LDL-C, and diabetes, strong behavioral measures
are now available for control of these major risk factors. In
the Nurses’ Health Study 82% of CHD incidence occurred in
those who failed to adhere to a sustained regimen that incor-
porates healthy dietary choices along with moderate exercise,
maintaining a normal body weight, smoking abstinence, and
moderate alcohol intake. Also, in the Health Professionals
Follow-Up Study adherence to this healthy lifestyle reduced
the lifetime risk of heart failure [3, 4].
3.1. Established Nutritional Factors. Evidence has now accu-
mulated that quantifies and substantiates accepted rec-
ommendations for consumption of cholesterol, saturated,
polyunsaturated, and transfats in the diet. In addition, new
data suggest that some foods we were told to avoid may be
acceptable if consumed in moderation.
3.1.1. Replacing Saturated Fat with Polyunsaturated Fat.
People have been advised to avoid eating saturated fats to
preserve CVD health for 60 years or more. However, there
has been little evidence from research to substantiate this
recommendation. The food industry and the general public
have reduced saturated fat over the years, but have often
replaced them with harmful trans fats and refined carbohy-
drates. A recent study by the Harvard School of Public Health
has produced the first conclusive evidence that reducing
saturated fat with polyunsaturated fat substitution reduces
CHD risk by 19%. The meta-analyses of 8 randomized trials
revealed that for every 5% increase in polyunsaturated fat
consumed, the risk of CVD decreased by 10%. The Institute
of Medicine recommends that 5%–10% of energy intake
should come from polyunsaturated fats. Other trials have
advised an intake of 15% [5].
3.1.2. Processed versus Unprocessed Red Meats. Probing of
the influence of saturated fat and cholesterol in the diet has
now been examined from the real-world perspective of the
marketplace. For example, a unique meta-analysis of globally
obtained data reported an examination of the relationship
between eating processed as opposed to unprocessed red
meats and the risk of CHD and diabetes. The analyses
indicated a direct relationship between consumption of
processed meats and the risk of CHD and diabetes. After
adjustment for CHD risk factors, the risk of CHD increased
by 42% and the risk of diabetes increased by 19% for
every 50 gm of processed meat consumed daily. Processed
meats, for example, bacon, sausages, or luncheon meats are
preserved by adding salt, smoking, curing, or by adding
preservatives. A 50 gm serving would be equivalent to a
hot dog or 1-2 slices of processed meat. The amount of
cholesterol and saturated fat contained in both processed and
unprocessed meat is comparable. However, the amount of
sodium in processed meats is four times greater than that
of unprocessed and it has 50% more nitrate preservatives.
The results of this study suggest that it is the sodium and
preservatives in processed red meats, and not the fats that
increase its risk of CVD and diabetes. Dietary salt does
increase blood pressure, and studies of animals suggest
that nitrate preservatives contribute to atherosclerosis and
decrease glucose intolerance; conditions that are known
to raise CHD and diabetes risk [6]. However, it is not
established that processed meat confers a higher CHD risk
than unprocessed meat.
3.1.3. Hazards of Red, White, and Processed Meats. A study
of the relationship between white, red, and processed meat
with mortality in half a million middle-aged participants of
the NIH-AARP Diet & Health Study was recently reported
by Sinha et al. Consumption of processed and red meats
was found to increase total deaths, cancer, and CVD deaths,
whereas white meat protected against total mortality and
cancer mortality. Red meat appeared to increase all the
specified mortalities more than the processed meats. Red
meat increased overall mortality 31% in men and 35% in
women, whilst processed meat increased it 15% and 25%
in men and women, respectively. For cancer mortality there
was a 27% increase for red meat for men and 50% increase
for women, whereas processed meat conferred a lesser 12%
increase in men and 11% in women. For CVD, red meat
imposed a 27% increase in men and 50% in women, while
for processed meat the increases were 9% in men and 38% in
women [7].
Unlike meat products that are high in fat, fish is
low in saturated fats and is a good source of protein
and omega-3 fatty acids. Omega-3 fatty acid has been
linked to a reduction in the development of atherosclerotic
plaque, triglyceride levels, blood pressure, and the risk of
arrhythmias. Consumption of fatty fish high in omega-3 fatty
acids such as salmon, sardines, and tuna at least twice per
week is recommended for preserving cardiovascular health.
Furthermore, Omega-3 fatty acid intake from food rather
than from supplements is advisable. However, for persons
with established coronary disease it may be advisable to also
prescribe a supplement of omega-3 [8].
Consideration of the type of fish to be consumed as well
as the means of preparation is also necessary. Due to the
high levels of contaminants and mercury contained in some
larger fish, such as swordfish and king mackerel, the USA
Food and Drug Administration recommend that children,
expectant women, and nursing mothers avoid consumption
of these fish and opt for fish that are lower in mercury such
as, salmon, catfish, and canned light tuna. For the middle-
aged and the elderly, eating an assortment of fish to help
diminish the detrimental effects of potential impurities is
recommended [8]. The cardioprotective benefits of eating
fish are dependent not only on the quantity and the type
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of fish consumed, but also the way that it is prepared.
Meng et al. found that men who ate the most fish had
a 23% decrease in coronary heart disease and those who
ate adequate amounts of baked or boiled fish had a lower
coronary disease death rate than those who ate little fish. On
the other hand, those who ate deep fried, salted, and dried
fish daily had an increase in CHDmortality of 12%–15% [9].
Hu et al. provide evidence supporting recommendations
to eat fish for cardioprotection. They found that 84,000
women nurses enrolled in the Nurses’ Health study who
consumed higher amounts of fish and omega-3 fatty acid
supplements have a reduced risk of CHD. Within a 16 year
observational period, 1,513 cases of incident CHD occurred,
484 CHD mortalities and 1,029 nonfatal myocardial infarc-
tions. Women who consumed a higher amount of fish had a
lower risk of coronary disease compared to those who ate fish
less than once per month. A comparable result was found for
those who consumed higher amounts of omega -3 fatty acids.
The protective relationship appeared to be more powerful for
coronary mortality than for nonfatal myocardial infarction
[10].
Contrary to the aforementioned research studies and
recommendations, Nair and Connolly did not find convinc-
ing evidence to support the recommendation for routine
consumption of omega-3 fatty acids. They reported that
Jenkins and colleagues failed to demonstrate a convincing
beneficial effect for prevention of arrhythmia and concluded
that cited meta-analyses had provided weak evidence that
omega-3 fatty acid intake can prevent either ventricular
arrhythmia or cardiovascular mortality [11].
3.1.4. Egg Consumption. As early as 1982 Dawber et al. of
the Framingham study reported on the nutrient intake of a
subsample of Framingham study participants that allowed
an estimate of egg consumption on 912 subjects. It was
concluded that within the range of egg intake of this general
population sample egg consumption is unrelated to serum
cholesterol or to CHD incidence [12].
In 1999 Hu et al. reported findings from the Health
Professionals Study and Nurses’ Health Study that prospec-
tively examined consumption of eggs as a risk for initial
CVD events in subjects free of high cholesterol, diabetes, or
cancer. There were 1805 initial CHD and 821 first strokes in
8 years. Adjusting for age, smoking, and other risk factors,
they found no significant link between 1–6 eggs weekly and
coronary heart disease or stroke risk in either sex. However,
egg use was associated with a statistically significant 1.5-
2-fold increased coronary disease risk in diabetic men and
women on comparison of consumption of more than 1 egg
daily versus less than 1 egg per week. They concluded that
eating one or fewer eggs per day has little impact on risk of
coronary disease or stroke in healthy persons but that egg
consumption in diabetics warrants further study [13].
A later study of egg consumption in the Physicians’
Health Study by Djousse´ et al. in 2008 examined the
relationship between egg intake and the risk of CVD events
and mortality prospectively in 21,327 participants. Over
the 20 year period, there were 8061 new events; 19% of
which were new myocardial infarctions, 17% initial strokes,
and 64% deaths. After adjustment for other risk factors
multivariable analysis showed that consumption of eggs
was unrelated to incident myocardial infarction or stroke,
however with respect to mortality there is a modest relation-
ship particularly in diabetics where the risk was increased
twofold (P for interaction = 0.09). It does not appear that
physicians need to restrict moderate egg consumption in
patients, unless they are diabetic [14].
3.2. Novel Dietary Factors. Recent research of modifiable
elements of behavior has reported findings that are contra-
dictory to some common perceptions about nutrition. Many
lifestyle elements that were once believed to be detrimental to
health do not appear to be damaging and in some cases are
beneficial. Among the novel factors reported in recent studies
are consumption of coffee, dark chocolate, nuts, orange juice
and vitamin D.
3.2.1. Coffee Consumption. There has been a long standing
controversy about the effect of coffee on CVD risk with early
studies finding it harmful and recent ones judging it helpful
or harmless. Until recently, studies have reported that coffee
lovers risk having excess cardiac rhythm disturbances as well
as myocardial infarctions and coronary heart disease in gen-
eral. In a review of coffee consumption and cardiovascular
disease in 1989 Wilson et al. called attention to a prospective
study of 45,589 subjects that reported only a trivial increase
in CVD risk for persons who consume more than 4 cups of
coffee per day, whereas there was a strong positive correlation
between decaffeinated coffee and the risk of CHD [15].
More recent large studies have reported that coffee actu-
ally does not increase CVD risk and may even decrease the
rate of CVD events. These include the Nurses’ Health Study
that reported no association between coffee consumption
and CVD occurrence in a study of 85,747 women who
were followed for 10 years, a Swedish study found no
association between coffee and post-MI death and an inverse
relationship between coffee consumption and CHD and a 6-
year study of 2,975 men cited by Wilson et al. that reported,
that the risk of a first cardiovascular event was decreased by
67% for those who drank more, rather than less, than 8 cups
of coffee per day [15]. In addition, Ahmed et al. opposed
the claim that coffee consumption increases the risk of heart
failure [16].
Further studies have also indicated a beneficial effect
of coffee. A recent NHANES prospective study found a
strong protective association of coffee in elders without
HBP. This finding was tested in the Framingham Study
on 1,354 subjects aged 65–97 years. There were 210 CVD
deaths and 118 CHD deaths during 10 years of surveillance.
A significant 43% inverse relation between caffeinated coffee
use and CHD mortality was observed for subjects with BP
< 160/100mmHg. This lowered risk appears to be primarily
attributable to a protective relationship between caffeinated
coffee use and the onset of heart valve disease [17].
Most physicians and their patients believe that “palpita-
tions” can result from drinking caffeinated coffee. However,
after adjustment of cholesterol, BMI, BP, and other risk
factors Kaiser Permanente investigators found that drinking
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more than 4 cups of coffee daily resulted in an 18% reduction
in hospitalizations for cardiac rhythm disturbances in men
and women, in different ethnic groups, and in smokers. An
analysis of the risk reduction of decaffeinated coffee resulted
in no protection, indicating that caffeine may actually be
protective [18].
3.2.2. Sugar Consumption. USA sugar consumption has
increased greatly in recent decades, largely due to added
sugars in foods processed to increase their desirability. In
an analysis of nutritional US data, Welsh et al. found a
correlation between the consumption of sweeteners and
blood lipid levels. This Emory University study analyzed the
data of more than 6,000 men and women from 1999–2006.
They found that people who add more sugar to their diet are
more likely to have higher triglycerides and triglyceride/high-
density lipoprotein cholesterol ratios. Highest consumers ate
46 teaspoons of added sugars daily, the lowest 3 teaspoons
daily [19]. This study, the first to examine the relation
between added sugars and lipids, did not evaluate natural
sugars in fruits and juices.
National surveys show that adding dietary sugar is
contributing to overconsumption of calories. Johnson et
al. postulate that the detrimental effect of elevated sugar
consumption during a pandemic of obesity and CVD is
cause for alarm. Between 1970 and 2005, dietary sugar intake
increased by 19% to the current level of 22.2 teaspoons
per day. The additional sugar appears to come chiefly from
excessive intake of beverages. This high consumption of soft
drinks replaces some essential nutrients and predisposes its
association with adiposity and the “metabolic syndrome.”
As a consequence the American Heart Association advises
limiting daily intake of sugar to less than 100 calories for
women and less than 150 calories for men [20].
3.2.3. Glycemic Diet. Prospective studies of the relationship
between glycemic load (GL) and glycemic index (GI) with
CVD have yielded inconsistent results, especially for men.
Sieri et al. investigated this issue in a 7.9 year follow-up study
of 47,749 EPICOR study volunteers who had completed a
nutritional survey. Over the follow-up period, 158 women
and 305men developed CHD.Women in the highest quartile
of carbohydrate consumption experienced a doubling of
CHD risk compared to those in the lowest quartile. However,
the same analysis in men yielded no association. Excess
intake of carbohydrate foods with a high-glycemic index
raises the blood sugar level and increases insulin resistance.
This imposes a significant 1.7-fold excess of CHD for women
only. For those in the highest quartile as opposed to those
in the lowest quartile CHD risk was increased more than
2-fold. It is postulated that the adverse effects of a high
glycemic diet in womenmay be attributable to sex differences
in lipoprotein and glucose metabolism [21].
Switching to a low glycemic diet can be relatively easy.
As recommended by the Glycemic Index Foundation Sydney
Australia, the basic premise is to substitute high glycemic
index carbohydrates for low glycemic carbohydrates. This
entails use of oats, barley and bran in breakfast cereals; eating
wholegrain breads and cutting down on the amounts of
potatoes consumed. All other types of fruits and vegetables
can be savored along with basmati rice, pasta, noodles,
quinoa and salad vegetables with a vinaigrette dressing [22].
3.2.4. Chocolate. Recent data suggest that eating chocolate
may actually lower blood pressure and risk of CVD. In a large
European study of more than 19,000 volunteers, Buijsse et al.
found that participants eating 7.5 grams of chocolate daily
had a lower risk of myocardial infarction and stroke than
those who consumed only 1.7 g of chocolate per day. During
the 8 years of the study, there were 166myocardial infarctions
and 136 strokes. The top quartile of chocolate consumers had
a 27% reduced risk of myocardial infarction and 48% lower
risk of stroke than the lowest quartile chocolate consumers.
The combined outcome of myocardial infarction and stroke
was reduced 39% (P = .01). Chocolate and cocoa have
a marked effect on blood pressure and in this study the
lower blood pressure induced accounted for 12% of the
reduction in CVD risk. However, even after adjusting for
blood pressure, those in the top chocolate consumption
quartile still had a 32% decreased risk of CVD compared to
those in the bottom quartile [23].
To date, there is no established recommendation for
healthful chocolate consumption for the purpose of pre-
serving cardiovascular health. Flavonoids in cocoa oppose
free radical injury because of their antioxidant effect. They
also decrease cholesterol, lower blood pressure, inhibit sticky
platelets, and improve blood flow to vital organs. During
the processing of cocoa into chocolate some of its beneficial
flavonoids are lost. Adding dark chocolate to the diet appears
preferential to eating milk chocolate. However, despite the
potential health benefits, one must recognize that 100 g of
dark chocolate has 500 calories, which must be taken into
account if weight gain is to be avoided. Presently, it appears
prudent to enjoy moderate one ounce portions of chocolate
several times a week. Other options for supplementing
the diet with flavinoid-rich foods are apples, cranberries,
grapes, onions, peanuts, orange juice, red wine, and tea
[24].
3.2.5. Nut Consumption. It appears that eating nuts as part
of a balanced diet may favorably affect blood lipids and
potentially lower the risk of CHD. Epidemiological studies
indicate that the risk of CHD is 40% lower in persons who
eat more than 4 servings of nuts per week as opposed to
those who do not eat any. A meta-analysis of 25 studies
undertaken by Sabate´ et al. examined whether the effects of
eating nuts on blood lipids vary by population, type of nuts
consumed, diet, or BMI in untreated subjects with normal
lipids and blood pressure. The results of this analysis indicate
that consuming 67 g of nuts daily reduced total cholesterol
by 10.9mg/dL and LDL-C 10.2mg/dL. It also significantly
improved the ratios of LDL/ HDL cholesterol and total/HDL
cholesterol. However, there was no significant effect onHDL-
C or triglycerides per se. The risk effect was similar in both
sexes and all age groups, and it was observed regardless of
the specific nut consumed. Lipid lowering was greater for
persons with higher LDL-C (18.4mg/dL) than lower LDL-C
(3.5mg/dL) and a BMI < 25 [25].
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3.2.6. Orange Juice. A new study claims that drinking orange
juice with meals can counter the proinflammatory effects
of high-carbohydrate, high-fat meals. High carbohydrate,
high fat meals induce a protein, suppressor of cytokine
signaling 3 (SOCS-3), that interferes with the action of
insulin promoting insulin resistance. These adverse changes
can be avoided when orange juice is consumed with a meal.
This implies that drinking orange juice could potentially help
prevent insulin resistance, diabetes, CHD and strokes. This
benefit may be attributable to the flavinoids in orange juice,
which suppress reactive oxygen metabolites [26].
3.2.7. Vitamin D. New studies support the link between
vitamin D deficiency and CVD [27–35]. Bair et al. observed
9.491 persons with low-level vitamin D and those who
normalized D levels after one year comparing outcomes in
CHD, MI and heart failure, stroke, renal failure, and death.
They found that those who normalized vitamin D levels were
less likely to develop heart failure or CVD, and they were
less likely to die [27]. The effect of vitamin D was quantified
in a study by May et al. who divided 31289 patients into 3
levels and linked them with several adverse outcomes, mostly
CVD. An inverse relationship was found between increasing
vitamin D levels and adverse events. Optimal vitamin D was
defined as greater than 43 nanograms per milliliter (ng/mL)
[28]. Penckofer et al. indicate a further benefit showing
that adequate intake of vitamin D may impede diabetes.
They postulate that vitamin D may aid in the regulation of
metabolic factors via beta-cell operation [29].
Vitamin D deficiency also appears to lead to high blood
pressure. In a study of premenopausal women with deficient
vitamin D levels, Griffin et al. found that after 15 years,
women whose vitamin D levels remained deficient, (less than
80 nmol/L), had a three times greater risk of developing
hypertension than those women whose vitamin D levels were
normal [30]. In the Framingham Study, Wang et al. found
that persons with >15 ng/mL versus <15 ng/mL vitamin D
had a multivariable adjusted hazard ratio of 1.62 (P < .01)
for new CVD, but only in hypertensive subjects (HR 2.13)
[31]. Evidently the health benefits of vitamin D go beyond
strong bones, protecting against CVD and even boosting the
immune system [32].
However data reported on utility of vitamin D supple-
ments for the treatment, prevention, and reversal of many
health conditions such as hypertension, diabetes, obesity, and
CVD are inconsistent. In a systematic review of 5 prospective
studies of dialysis patients and one general population
study of subjects receiving vitamin D supplements, Wang
et al. found a decrease in CVD deaths [33]. However,
Pittas et al. found the association between vitamin D status
and cardiometabolic outcomes to be uncertain. Trials they
reviewed showed no clinically significant effect of vitamin D
supplementation [34]. Further studies may be necessary to
determine an optimum dosage of vitamin D.
Meanwhile, increasing vitamin D levels appears to be
necessary. Small amounts of vitamin D can be obtained
from foods such as fish and mushrooms as well as from
vitamin supplements. However, obtaining vitamin D from
sun exposure has a greater duration of effect. Although,
physicians usually advise patients to avoid unprotected
sun exposure, its beneficial effects are essential, albeit in
moderation. On exposure to the sun, the skin produces
vitamin D and preserves it in adipose tissue. Vitamin D
is then released when sunlight is limited such as in winter
months in the Northern Hemisphere. Ten minutes of sun
exposure daily is not only safe, but necessary for optimal
health. In person over 65 years of age and for residents living
in areas where sun exposure is limited, a dietary supplement
is recommended [29, 35].
3.3. Portion Control for Weight Management. Portion control
is essential for weight loss and for maintaining a healthy
weight. In 2007, Pederson et al. completed a randomized trial
of weight control in 130 participants with type 2 diabetes.
The group using a portion-control plate decreased their body
weight by 1.75% versus a 0.05% weight loss in the group
who did not. The group using the portion-control plate also
decreased use of medication for the management of diabetes,
suggesting that portion-control plates are as effective as
costly diet medication [36]. The diet plate is a commercially
available plate with recommended foods and serving sizes for
a healthful diet depicted on it.
When presented with greater portion sizes, people tend
to eat more but report the same level of satiation. In a study
by Rolls et al. participants were given four different portion
sizes of macaroni and cheese on different days. Although,
consumption increased with the portion size served, par-
ticipants reported similar levels of satiation and less than
half noticed that portion sizes had changed. Consumption
of the largest portion as opposed to the smallest portion of
macaroni amounted to 30% more energy (162 cal) [37]. In a
similar study, the same participants were given different sizes
of subsandwiches on 4 different days. The participants ate
significantly more as the sandwich size increased [38] Rolls
et al. also examined how energy intake increases in both men
and women as the portion size of a snack increases. On 5
different occasions, they gavemen and women bags of potato
crisps that appeared to be similar in size but the quantity
varied from 28 g to 170 g. As the package size increased
the amount of consumption also increased [39]. A study
by Diliberti et al. showed similar effect in that participants
who were served different quantities on different days in a
restaurant, increased consumption as portion sizes increased
[40]. Increased portion size appears to make it difficult for
people to determine how much is being consumed and leads
to excess calorie consumption. Therefore, public awareness
of the effect portion size can have on weight control efforts is
essential [41].
3.4. Alcohol and Cardiovascular Disease. Meta-analyses of
experimental and observational studies indicate that mod-
erate consumption of alcohol is beneficial for decreasing
the risk of CHD. Published research has for many years
suggested a link between alcohol consumption and reduced
CVD mortality. Alcohol is associated with a modest increase
in HDL cholesterol and may play a role in reduction of
thrombus formation which reduces risk of stroke and CHD.
A study examining the effects of alcohol on cholesterol and
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haemostatic factors by Rimm et al. showed that consumption
of 30 g of alcohol per day can reduce risk of CHD by 24.7%
[42]. Some speculate that the benefits may derive from the
beneficial antioxidants and flavonoids contained in red wine.
However, it is unclear if the type of alcohol consumed,
or other healthy behaviors of those who consume alcohol
in moderation, is responsible for the reduced risk [43].
Nonetheless, Mukamal et al. found that moderate alcohol
consumption appears to confer a lower risk of myocardial
infarction even in men who were already determined to be
at low risk of MI based on their healthy lifestyle choices and
BMI [44]. Likewise, Sesso et al. found a significant reduction
in risk of CHD in men who increased consumption of
alcohol from very low to moderate levels. The study included
18,455 men who were tracked over a period of 7 years
[45].
The AHA reluctantly recommends moderate consump-
tion of no more than two drinks per day for men and one
drink per day for women. A drink is one 12 oz. beer, 4 oz. of
wine, 1.5 oz. of 80-proof spirits, or 1 oz. of 100-proof spirits.
It reminds us that drinking more alcohol than recommended
is associated with alcoholism, accidents, suicide, cirrhosis
of the liver, and breast cancer. With consideration of the
detrimental effects, the AHA does not recommend that
abstainers start drinking alcohol [46].
4. Discussion
4.1. Magnitude of the Cardiovascular Threat. The Fram-
ingham study has determined the actual lifetime risk of
developing atherosclerotic cardiovascular disease from a
general population sample examined biennially since 1950.
In the 60 years of surveillance by routine examination of the
population, the lifetime risk of developing a cardiovascular
event for a 50-year-old was 52% for men and more than
39% for women with little or suboptimal treatment [47–
50]. Ford et al. estimate that half the reduction in USA
CHD mortality since 1980 is attributable to cardiovascular
risk factor reduction in the population [51] Thus, correction
of risk factors discovered by the Framingham study has
resulted in a major reduction in CHD deaths in the US
population; 64% for non-CHD deaths and 49% for sudden
deaths [52]. A faulty diet is in part responsible for many
of the major CVD risk factors including dyslipidemia,
hypertension, obesity, impaired glucose tolerance, and
diabetes.
4.2. Lifestyle and Behavior. The USA allocates more funds
for its medical system than any other country but performs
poorly on all measures for the quality of health care. In
comparison with 30 developed nations of the world, the US
trails behind on most standard measures of quality health
care. Reports based on 2004 data from 192 nations, placed
the USA at 46th in average life expectancy and 42nd in
infant mortality. Whereas a mere 10% of the population’s
mortality is attributable to the quality of health care and 40%
is attributable to detrimental behaviors, the best means for
improving health and reducing premature death may lie in
the modification of personal behavior [53, 54]. Physicians
need to place greater emphasis on modifying patient’s CVD-
promoting behavior and among these, a more healthy diet
warrants a high priority.
5. Conclusion
A healthy lifestyle for avoiding CVD and its predisposing
risk factors and thus prolonging lifespan must include a
healthy diet that has many features of a Mediterranean or
Oriental cuisine. Recent trials and data suggest that certain
nutrients formerly indicted as harmful need not be avoided
including moderate consumption of eggs, chocolate, nuts,
and caffeinated coffee, among others. Recommendations for
prevention of CVD have much in common regarding CVD
risk factors. Nutritional risk factors appear to apply for
more than dyslipidemia. For hypertension recommendations
include a lean body mass, restricted sodium intake, and a
diet that emphasizes fruits and vegetables, and low-fat dairy
products. For Diabetes recommendations include curbing
weight gain, control of blood pressure and lipids by eating a
balanced diet. For a reduced HDL-C one should also control
weight and eat fatty fish (e.g., salmon, sardines, and tuna).
For Obesity requirements include control of food portion
size. For a healthy LDL-C one must eat less saturated fat,
trans fatty acids, fewer calories and cram up on whole grains
(at least 3 servings a day) eat 6 ounces of fattier fish and
gorge on fruits, vegetables, and legumes (6 servings a day).
Dietary lifestyle and behavior modification can play a major
role in avoiding and correcting risk factors for CVD a major
determinant of longevity.
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